메뉴 건너뛰기




Volumn 49, Issue 5, 2008, Pages 384-387

Allopurinol hypersensitivity syndrome: A preventable severe cutaneous adverse reaction?

Author keywords

Allopurinol; Cutaneous adverse reaction; Drug hypersensitivity; Drug induced hypersensitivity syndrome; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL;

EID: 44149110334     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (88)

References (22)
  • 1
    • 0036286849 scopus 로고    scopus 로고
    • The association between gout and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988-1994
    • Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002; 40:37-42.
    • (2002) Am J Kidney Dis , vol.40 , pp. 37-42
    • Kramer, H.M.1    Curhan, G.2
  • 2
    • 0036231531 scopus 로고    scopus 로고
    • Gout and hyperuricemia
    • Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol 2002; 14:281-6.
    • (2002) Curr Opin Rheumatol , vol.14 , pp. 281-286
    • Wortmann, R.L.1
  • 4
    • 0022871147 scopus 로고
    • The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality
    • Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986; 29:82-7.
    • (1986) Arthritis Rheum , vol.29 , pp. 82-87
    • Singer, J.Z.1    Wallace, S.L.2
  • 5
    • 0021366307 scopus 로고
    • Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency
    • Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76:47-56.
    • (1984) Am J Med , vol.76 , pp. 47-56
    • Hande, K.R.1    Noone, R.M.2    Stone, W.J.3
  • 6
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1):S1-200.
    • (2002) Am J Kidney Dis , vol.39 , Issue.2 SUPPL. 1
  • 7
    • 33745894681 scopus 로고    scopus 로고
    • Variability in the clinical pattern of cutaneous side-effects with systemic symptoms: Does a DRESS syndrome really exist?
    • Peyrière H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006; 155:422-8.
    • (2006) Br J Dermatol , vol.155 , pp. 422-428
    • Peyrière, H.1    Dereure, O.2    Breton, H.3
  • 8
    • 27144533642 scopus 로고    scopus 로고
    • Allopurinol-induced DRESS syndrome
    • Markel A. Allopurinol-induced DRESS syndrome. Isr Med Assoc J 2005; 7:656-60.
    • (2005) Isr Med Assoc J , vol.7 , pp. 656-660
    • Markel, A.1
  • 9
    • 0027407458 scopus 로고
    • Allopurinol hypersensitivity syndrome: A review
    • Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother. 1993; 27:337-43.
    • (1993) Ann Pharmacother , vol.27 , pp. 337-343
    • Arellano, F.1    Sacristán, J.A.2
  • 10
    • 33744992913 scopus 로고    scopus 로고
    • Diagnosis and management of gout
    • Underwood M. Diagnosis and management of gout. BMJ 2006; 332:1315-9.
    • (2006) BMJ , vol.332 , pp. 1315-1319
    • Underwood, M.1
  • 11
    • 0142123411 scopus 로고    scopus 로고
    • Terkeltaub RA. Clinical Practice. Gout. N Engl J Med 2003; 349:1647-55.
    • Terkeltaub RA. Clinical Practice. Gout. N Engl J Med 2003; 349:1647-55.
  • 12
    • 1442303074 scopus 로고    scopus 로고
    • Is a drug alone sufficient to cause the drug hypersensitivity syndrome?
    • Wong GA, Shear NH. Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch Dermatol 2004; 140:226-30.
    • (2004) Arch Dermatol , vol.140 , pp. 226-230
    • Wong, G.A.1    Shear, N.H.2
  • 13
    • 33745906565 scopus 로고    scopus 로고
    • Reactivation of human herpes virus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
    • Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpes virus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006; 155:344-9.
    • (2006) Br J Dermatol , vol.155 , pp. 344-349
    • Seishima, M.1    Yamanaka, S.2    Fujisawa, T.3    Tohyama, M.4    Hashimoto, K.5
  • 14
    • 0023196329 scopus 로고
    • Use and abuse of allopurinol
    • Cameron JS, Simmonds HA. Use and abuse of allopurinol. Br Med J 1987: 294:1504-5.
    • (1987) Br Med J , vol.294 , pp. 1504-1505
    • Cameron, J.S.1    Simmonds, H.A.2
  • 15
    • 0032847798 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmocodynamics of allopurinol in elderly and young subjects
    • Turnheim K, Krivanek P, Oberbauer R. Pharmacokinetics and pharmocodynamics of allopurinol in elderly and young subjects. Br J Clin Pharmacol 1999; 48:501-9.
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 501-509
    • Turnheim, K.1    Krivanek, P.2    Oberbauer, R.3
  • 16
    • 20844447189 scopus 로고    scopus 로고
    • Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: Another insight to allopurinol-related toxicity
    • Perez-Ruiz F, Hernando I, Villar I, Nolla JM. Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity. J Clin Rheumatol 2005; 11:129-33.
    • (2005) J Clin Rheumatol , vol.11 , pp. 129-133
    • Perez-Ruiz, F.1    Hernando, I.2    Villar, I.3    Nolla, J.M.4
  • 17
    • 0033773721 scopus 로고    scopus 로고
    • The optimal use of allopurinol: An audit of allopurinol use in South Auckland
    • Stamp L, Gow P, Sharples K, Raill B. The optimal use of allopurinol: an audit of allopurinol use in South Auckland. Aust N Z J Med 2000; 30:567-72.
    • (2000) Aust N Z J Med , vol.30 , pp. 567-572
    • Stamp, L.1    Gow, P.2    Sharples, K.3    Raill, B.4
  • 18
    • 33745610176 scopus 로고    scopus 로고
    • Gout medication treatment patterns and adherence to standards of care from a managed care perspective
    • Sarawate CA, Brewer KK, Yang W, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006; 81:925-34.
    • (2006) Mayo Clin Proc , vol.81 , pp. 925-934
    • Sarawate, C.A.1    Brewer, K.K.2    Yang, W.3
  • 19
    • 0032804865 scopus 로고    scopus 로고
    • Familial hypersensitivity to allopurinol with subsequent desensitization
    • Melsom RD. Familial hypersensitivity to allopurinol with subsequent desensitization. Rheumatology (Oxford) 1999; 38:1301.
    • (1999) Rheumatology (Oxford) , vol.38 , pp. 1301
    • Melsom, R.D.1
  • 20
    • 15244349566 scopus 로고    scopus 로고
    • HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
    • Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102:4134-9.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 4134-4139
    • Hung, S.I.1    Chung, W.H.2    Liou, L.B.3
  • 21
    • 0033936414 scopus 로고    scopus 로고
    • A review of inpatients with adverse drug reactions to allopurinol
    • Khoo BP, Leow YH. A review of inpatients with adverse drug reactions to allopurinol. Singapore Med J 2000; 41:156-60.
    • (2000) Singapore Med J , vol.41 , pp. 156-160
    • Khoo, B.P.1    Leow, Y.H.2
  • 22
    • 0036106093 scopus 로고    scopus 로고
    • Allopurinol hypersensitivity syndrome and acute myocardial infarction - two case reports
    • Chan YC, Tay YK, Ng SK. Allopurinol hypersensitivity syndrome and acute myocardial infarction - two case reports. Ann Acad Med Singapore 2002; 31:231-3.
    • (2002) Ann Acad Med Singapore , vol.31 , pp. 231-233
    • Chan, Y.C.1    Tay, Y.K.2    Ng, S.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.